The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

For patients with inadequately controlled type 2 diabetes receiving dulaglutide, switching to tirzepatide is associated with additional hemoglobin A1c (HbA1c) reduction and weight loss compared with ...

Today at the American College of Physicians (ACP) annual meeting, Internal Medicine Meeting 2025, in New Orleans, Annals of ...

For patients with inadequately controlled type 2 diabetes receiving dulaglutide, switching to tirzepatide is associated with additional hemoglobin A1c (HbA1c) reduction and weight loss compared with ...

Trump previously floated a 25% tariff on all imported drugs, though they were unaffected by recent reciprocal levies.

The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers.

Authors discuss research on AI in the exam room, switching GLP1-RAs for better glucose and weight control, and ACP's best ...

The General Directorate of Drugs, Food, and Health Products (Digemaps) issued a public warning about unapproved weight-loss ...

Jim Cramer in a latest program on CNBC urged investors to start accepting the reality of the new economic system under ...

To prevent muscle loss, more physicians are emphasizing the importance of fat loss vs weight loss for patients taking GLP-1 ...

The first of nine trailblazer programmes to get people back into work has begun in South Yorkshire, with GPs helping to ...